Cabergoline Targets Multiple Pathways to Inhibit PRL Secretion and Increases Stromal Fibrosis

By sjmartinez • May 24, 2024

Zhang D, Hugo W, Bergsneider M, Wang MB, Kim W, Han K, Vinters HV, Heaney AP. Cabergoline Targets Multiple Pathways to Inhibit PRL Secretion and Increases Stromal Fibrosis. Eur J Endocrinol. 2024 May 23:lvae055. doi: 10.1093/ejendo/lvae055. Epub ahead of print. PMID: 38781434.

Tags: Cabergoline, Dermatology, Endocrinology, Pituitary tumor, Prolactinomas, Publications, ScRNAseq, tumor microenvironment

A Response to: “Letter to the Editor Regarding ‘Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis'”

Augustin M, Armstrong AW, Issa NT, Petersen AS, von Eyben R, Festini T, Torres T. A Response to: "Letter to the Editor Regarding 'Anchored Matching-Adjusted[...]

Long-term disability outcomes in Hansen’s disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy

Ma EJ, Adler BL, Armstrong AW, Ochoa MT. Long-term disability outcomes in Hansen's disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy. PLoS Negl[...]

Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial

Armstrong AW, Roberts AM, Kostandy G, Choudhury F, Yee D, Luu M, Jones ME, Alizadeh ER, Cotliar J, Chren MM, Gelfand JM, Cockburn M, Doctor[...]